You are here: Industry Insights > COVID-19

News List

Research finds decrease in radiotherapy treatments due to COVID-19 pharmatimes
January 27, 2021
New research has revealed ‘dramatic changes’ in the delivery of radiotherapy treatments for cancer during the first wave of the COVID-19 pandemic in England.
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial contractpharma
January 27, 2021
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.
Elasmogen Announces Panel of Anti-COVID-19 Therapeutic Candidates americanpharmaceuticalreview
January 27, 2021
Elasmogen has announced a breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping COVID-19 infections.
Syntekabio, Hanmi to Co-Develop COVID-19 Treatments Using Drug Repurposing Technologies americanpharmaceuticalreview
January 27, 2021
Syntekabio and Hanmi Science have entered into a strategic collaboration to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.
Misinformation, future of work among key pharma trends in 2021: GlobalData expresspharma
January 27, 2021
The pharma industry will be shaped by several emerging trends in 2021. The industry will need to adapt quickly post-COVID-19 by overcoming the spread of online misinformation and preparing for a new way of working, says GlobalData.
Increased heparin dose reduces need for life support in hospitalised COVID-19 patients europeanpharmaceuticalreview
January 26, 2021
Interim data from 1,000 hospitalised patients with moderate COVID-19 symptoms shows that full doses of heparin can improve patient outcomes and could reduce ICU burden.
NHS COVID-19 vaccination drive bolstered by new centres pharmatimes
January 26, 2021
More than 30 new vaccination centres are set to open across England in a bid to bolster the NHS’ COVID-19 vaccination drive.
Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative prnewswire
January 26, 2021
?Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern California.
Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19 prnewswire
January 26, 2021
Tevogen Bio announced it has secured necessary funding from HMP Partners of New Jersey, an investment firm managed by medical doctors, which will allow Tevogen to support all clinical trials of its investigational, potentially curative COVID-19 treatment.
Senhwa Announces First Patient Enrolled in Silmitasertib Trial for Severe COVID-19 americanpharmaceuticalreview
January 26, 2021
Senhwa Biosciences announced that the first patient has enrolled into an investigator-initiated trial (IIT) of its investigational drug, Silmitasertib, as a treatment for hospitalized COVID-19 patients at Banner Health-University Medical Center in ...